Previous studies have shown that FBP1 could inhibit glycolysis in kidney cancer, and the expression of FBP1was significantly lower in patients with high-grade ccRCC than in patients with low-grade ccRCC [55]. The gene discussed is FBP1; the disease is kidney cancer.